Equities

PolyPid Ltd

PYPD:NAQ

PolyPid Ltd

Actions
  • Price (USD)3.46
  • Today's Change0.01 / 0.29%
  • Shares traded1.12k
  • 1 Year change-42.56%
  • Beta1.3115
Data delayed at least 15 minutes, as of Sep 19 2024 20:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

  • Revenue in USD (TTM)0.00
  • Net income in USD-24.70m
  • Incorporated2008
  • Employees59.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Talphera Inc398.00k-13.70m15.29m15.00--1.20--38.43-0.6353-0.63230.01850.74910.0187----26,533.33-64.37-22.60-78.11-28.55-----3,443.22-714.87----0.00-----21.26-119.16---34.33--
Cara Therapeutics Inc11.00m-111.08m15.69m55.00--1.35--1.43-2.04-2.040.20170.21150.10631.102.10199,927.30-107.38-35.76-132.61-40.8274.66---1,010.20-162.104.48--0.00---49.929.26-38.65--100.66--
DH Enchantment Inc100.00-173.19k16.09m1.00------160,915.00-0.0002-0.00020.00-0.00120.04380.1493--100.00-7,579.43------0.00---173,190.00--0.0029-14.85-----95.43--59.53------
Nexgel Inc5.01m-3.39m17.19m19.00--3.85--3.43-0.5722-0.57220.84640.65890.49423.036.44263,631.60-35.74-44.61-48.15-56.1923.745.02-72.33-180.980.8135--0.1992--99.6613.0633.48------
Cumberland Pharmaceuticals, Inc.37.79m-10.38m17.62m91.00--0.6681--0.4663-0.7328-0.73282.671.870.45010.86433.17415,225.80-12.35-7.03-17.75-9.5282.5879.95-27.45-17.641.26-38.850.382---5.856.15-12.73---36.17--
Cyclo Therapeutics Inc1.13m-20.74m18.68m8.00------16.50-0.9104-0.91040.0474-0.17850.2420.400213.16141,553.80-443.08-132.22---215.1791.5690.37-1,831.29-1,114.040.4283-------21.761.25-29.81---3.95--
TherapeuticsMD Inc996.00k-4.83m19.14m1.00--0.6918--19.22-0.4348-0.55380.08892.400.0212--0.5048996,000.00-10.31-53.35-13.13-111.6145.0886.67-485.34-236.57----0.00---98.14-39.53-816.85------
China Health Industries Holdings, Inc.95.95k-1.36m21.30m32.00------221.99-0.0208-0.02080.0015-0.03660.00370.503520.572,998.44-5.183.04-6.893.66-5.3469.55-1,419.4928.610.0377--1.76--41,225.93-55.72-15.49------
Polypid Ltd0.00-24.70m24.26m59.00--10.34-----9.65-9.650.000.33370.00----0.00-107.89-76.92-164.39-89.61-----------24.210.8425------39.67---42.34--
Bio Essence Corp593.21k-1.02m25.09m12.00------42.29-0.0278-0.01560.0158-0.04580.3305--21.20---57.09-46.10----25.0533.89-172.74-111.21---59.997.03---11.27-10.94-52.03---48.19--
BioXcel Therapeutics Inc2.40m-107.83m25.96m74.00------10.80-3.56-3.560.074-1.840.02340.59413.8732,472.97-104.93-74.57-150.29-84.0643.07---4,487.39-32,300.742.25-10.103.59--268.00---8.02---43.26--
KALA BIO Inc0.00-38.72m26.72m43.00--1.94-----13.95-13.950.002.980.00----0.00-60.45-57.83-78.16-69.32--57.06---1,553.61---11.360.7174---100.00--5.85---17.31--
Acasti Pharma Inc0.00-11.45m27.58m32.00--0.4646-----1.22-1.220.005.850.00-------16.04-31.68-16.57-33.95-------56,271.43---37.800.00------69.71---47.16--
Dare Bioscience Inc2.84m-7.20m27.60m23.00--10.33--9.72-1.07-1.070.35790.31260.1213--3.85123,462.20-30.76-109.51-191.39-246.260.8477---253.60-1,104.55----0.00---71.92--2.54--121.37--
Incannex Healthcare Inc-100.00bn-100.00bn29.21m----2.07----------0.8907-----------54.94---59.47-------1,033.07----0.00--61.923.38-24.35--54.12--
Equillium Inc42.62m-8.32m30.11m45.00--1.34--0.7064-0.2377-0.23771.200.63330.8388--8.85968,704.60-16.37-46.81-29.58-57.36-----19.52-328.35----0.00--128.97--78.64--7.48--
Data as of Sep 19 2024. Currency figures normalised to PolyPid Ltd's reporting currency: US Dollar USD

Institutional shareholders

30.64%Per cent of shares held by top holders
HolderShares% Held
Rosalind Advisors, Inc.as of 06 Aug 2024679.69k14.17%
AIGH Capital Management LLCas of 30 Jun 2024479.25k9.99%
DAFNA Capital Management LLCas of 30 Jun 2024184.85k3.85%
Adar1 Capital Management LLCas of 30 Jun 2024103.95k2.17%
Yelin Lapidot Mutual Fund Management Ltd.as of 30 Jun 202411.15k0.23%
Steward Partners Investment Advisory LLCas of 30 Jun 20247.35k0.15%
UBS Securities LLCas of 30 Jun 20242.41k0.05%
Morgan Stanley & Co. LLCas of 30 Jun 2024732.000.02%
Osaic Wealth, Inc. (Investment Management)as of 30 Jun 2024467.000.01%
Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Jun 2024146.000.00%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.